<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id><journal-id journal-id-type="pmc-domain-id">2745</journal-id><journal-id journal-id-type="pmc-domain">jclinmed</journal-id><journal-id journal-id-type="publisher-id">jcm</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2077-0383</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11433274</article-id><article-id pub-id-type="pmcid-ver">PMC11433274.1</article-id><article-id pub-id-type="pmcaid">11433274</article-id><article-id pub-id-type="pmcaiid">11433274</article-id><article-id pub-id-type="pmid">39337088</article-id><article-id pub-id-type="doi">10.3390/jcm13185601</article-id><article-id pub-id-type="publisher-id">jcm-13-05601</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Long-Term Outcomes in Patients Managed with the Endurant<sup>TM</sup> Endograft under Elective Setting</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2891-777X</contrib-id><name name-style="western"><surname>Spanos</surname><given-names initials="K">Konstantinos</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-jcm-13-05601" ref-type="aff">1</xref><xref rid="c1-jcm-13-05601" ref-type="corresp">*</xref><xref rid="fn1-jcm-13-05601" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9060-8519</contrib-id><name name-style="western"><surname>Nana</surname><given-names initials="P">Petroula</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af2-jcm-13-05601" ref-type="aff">2</xref><xref rid="fn1-jcm-13-05601" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8682-7046</contrib-id><name name-style="western"><surname>Volakakis</surname><given-names initials="G">George</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-jcm-13-05601" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5443-2066</contrib-id><name name-style="western"><surname>Kouvelos</surname><given-names initials="G">George</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-jcm-13-05601" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4872-1811</contrib-id><name name-style="western"><surname>Dakis</surname><given-names initials="K">Konstantinos</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-jcm-13-05601" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Karathanos</surname><given-names initials="C">Christos</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-jcm-13-05601" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arnaoutoglou</surname><given-names initials="E">Eleni</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af3-jcm-13-05601" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Matsagkas</surname><given-names initials="M">Miltiadis</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-jcm-13-05601" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Giannoukas</surname><given-names initials="A">Athanasios</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-jcm-13-05601" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Oberhuber</surname><given-names initials="A">Alexander</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jcm-13-05601"><label>1</label>Department of Vascular Surgery, Larissa University Hospital, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece; <email>geo-vol@hotmail.com</email> (G.V.); <email>geokouv@gmail.com</email> (G.K.); <email>kostasdakis1994@gmail.com</email> (K.D.); <email>christos2001@hotmail.com</email> (C.K.); <email>milmats@gmail.com</email> (M.M.); <email>agiannoukas@hotmail.com</email> (A.G.)</aff><aff id="af2-jcm-13-05601"><label>2</label>German Aortic Centre, Department of Vascular Medicine, University Heart and Vascular Centre UKE Hamburg, 20246 Hamburg, Germany; <email>petr.nana7@hotmail.com</email></aff><aff id="af3-jcm-13-05601"><label>3</label>Department of Anesthesiology, Larissa University Hospital, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece; <email>earnaout@gmail.com</email></aff><author-notes><corresp id="c1-jcm-13-05601"><label>*</label>Correspondence: <email>spanos.kon@gmail.com</email>; Tel.: +30-6948570321</corresp><fn id="fn1-jcm-13-05601"><label>&#8224;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>21</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2024</year></pub-date><volume>13</volume><issue>18</issue><issue-id pub-id-type="pmc-issue-id">471627</issue-id><elocation-id>5601</elocation-id><history><date date-type="received"><day>26</day><month>8</month><year>2024</year></date><date date-type="rev-recd"><day>12</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-29 16:25:13.610"><day>29</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jcm-13-05601.pdf"/><abstract><p><bold>Background/Objectives</bold>: Device selection during endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) remains an important issue for ensuring endograft durability. This study evaluated the early and follow-up outcomes of elective EVAR with the Endurant platform. <bold>Methods</bold>: A single-center retrospective analysis was conducted including consecutive elective EVAR procedures with the Endurant II/IIs (2008 to 2024) device. Primary outcomes were technical success, mortality and major complications at 30 days. Survival, endoleak I/III and freedom from reintervention were secondary outcomes. Cox proportional hazards models were employed for risk-adjusted follow-up outcomes. <bold>Results</bold>: In total, 361 patients were included (72.7 &#177; 7 years; 96% males; mean AAA diameter 62 &#177; 14 mm); 92% received a bifurcated device, and 89% conformed to the instructions for use. Technical success was 99.7%. Intra-operative adjunctive procedures included 4.4% proximal cuffs and 1.7% endoanchors. The thirty-day mortality rate was 0.6%, and the major complication rate was 4.1%. Survival was 81% (SE 4.8%), 72% (SE 6.4%) and 52% (SE 9.2%) at 4, 6 and 8 years, with aneurysm-related mortality at 1.7%. Freedom from endoleak Ia was 76% (SE 7.3%) at 6 years, freedom from endoleak Ib was 79% (SE 7.4%) at 7 years and freedom from endoleak III was 94% (SE 3.7%) at 5 years. Freedom from reintervention was 71% (SE 6.1%) and 55% (SE 7.9%) at 5 and 7 years, respectively. No device-related co-factor affected long-term outcomes. <bold>Conclusions</bold>: Endurant II/IIs endograft is a safe and effective EVAR solution with excellent early outcomes and low long-term aneurysm-related mortality. The need for reintervention in the long term affected less than 50% of cases.</p></abstract><kwd-group><kwd>aneurysm</kwd><kwd>Endurant</kwd><kwd>endovascular repair</kwd><kwd>long-term outcomes</kwd><kwd>mortality</kwd><kwd>reintervention</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-jcm-13-05601"><title>1. Introduction</title><p>Endovascular aneurysm repair (EVAR) has become the standard treatment for abdominal aortic aneurysms (AAAs). Thus, for most patients with suitable anatomy and reasonable life expectancy, endovascular repair should be considered as the preferred treatment modality for elective abdominal aortic aneurysm repair according to the latest (2024) guidelines by the European Society of Vascular Surgery (ESVS; Class IIa, Level of Evidence B) [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>]. However, long-term durability remains still an issue, with EVAR showing higher reintervention rates and aneurysm-related mortality compared to open surgical repair [<xref rid="B2-jcm-13-05601" ref-type="bibr">2</xref>,<xref rid="B3-jcm-13-05601" ref-type="bibr">3</xref>,<xref rid="B4-jcm-13-05601" ref-type="bibr">4</xref>]. For this purpose, the recent ESVS guidelines presented a new recommendation highlighting that device selection should be considered based on aorto-iliac anatomy and the availability of unbiased long-term durability data (Class IIa, Level of Evidence C) [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>].</p><p>The Endurant stent graft (Medtronic Endovascular, Santa Rosa, Calif) has been widely used since receiving the CE mark in Europe in 2008. Robust data have been available from The Endurant Stent Graft Natural Selection Global Post-market Registry (ENGAGE) which is a global, prospective multicenter registry evaluating the Endurant stent graft system (Medtronic, Santa Rosa, CA, USA) and represents the largest registry for any single EVAR stent graft [<xref rid="B5-jcm-13-05601" ref-type="bibr">5</xref>]. The 10-year data of the ENGAGE registry showed good long-term outcomes with a 94.7% freedom from aneurysm-related mortality (ARM) and 64.1% sac regression at 10 years [<xref rid="B6-jcm-13-05601" ref-type="bibr">6</xref>]. Real-world data, out of registries, showed encouraging early and follow-up outcomes using the Endurant device for elective AAA management [<xref rid="B7-jcm-13-05601" ref-type="bibr">7</xref>].</p><p>Thus, the current study aimed to evaluate real-world early and long-term outcomes of the Endurant stent graft platform in elective AAA treatment in a tertiary reference center.</p></sec><sec id="sec2-jcm-13-05601"><title>2. Materials and Methods</title><sec id="sec2dot1-jcm-13-05601"><title>2.1. Study Design</title><p>A single-center retrospective analysis was conducted including consecutive patients managed electively with Endurant II/IIs for infra-renal abdominal aortic aneurysms (AAAs) between 2008 and 2024, and in accordance with the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines [<xref rid="B8-jcm-13-05601" ref-type="bibr">8</xref>]. This study complied with the Declaration of Helsinki, and ethical approval was waived, given the retrospective design and use of anonymized data.</p></sec><sec id="sec2dot2-jcm-13-05601"><title>2.2. Patient Population</title><p>All patients were treated using the Endurant II/IIs endograft (Medtronic, Santa Rosa, CA, USA), bifurcated or aorto-uni-iliac (AUI), under an elective setting for infra-renal AAAs. The indications to treat degenerative AAAs relied on the available aortic guidelines at the time of repair [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>,<xref rid="B9-jcm-13-05601" ref-type="bibr">9</xref>,<xref rid="B10-jcm-13-05601" ref-type="bibr">10</xref>]. Sizing and planning were performed by experienced vascular surgeons, based on a recent (within 3&#8211;6 months) pre-operative computed tomography angiography (CTA), using dedicated software (3Mensio, Medical Imaging B.V., Bilthoven, the Netherlands). All interventions were performed in an adequately equipped operating room, using a moveable radiolucent surgical table (2008&#8211;2019: Maquet, Getinge Group, Rastatt, Germany; 2019&#8211;2024: Stille Surgical, Inc., Torsh&#228;lla, Sweden) and a mobile digital angiographic system (2008&#8211;2019: Philips BV Endura, Philips Medical Systems, Release 2.2.3, Amsterdam, the Netherlands; 2019&#8211;2024: Ziehm Vision RFD Hybrid Edition, Ziehm Imaging, Nuremberg, GE).</p><p>Procedures were performed after appropriate anesthesiologic evaluation. The pre-operative work-up included cardiologic and pulmonary evaluation, with transthoracic echocardiography and spirometry, respectively. Further evaluation was decided depending on the patients&#8217; findings. According to the pre-operative assessment, patients were preferably managed using general anesthesia to provide optimal endograft deployment with elimination of respiratory movements. Epidural anesthesia and local anesthesia with monitored anesthesia care were used in the remaining cases.</p><p>Femoral access was performed using bilateral cut-down in all cases. The bifurcated Endurant device was used in most cases. Usually, a right access was preferred for main device advancement, and only when inadequate right access (&lt;7 mm diameter, severe stenosis &gt;70% or occlusion) was present, a left access was used. After an initial angiography for the identification of the lowest renal artery, the main device was deployed, and the contralateral limb was catheterized in standard fashion; this was followed by the deployment of both iliac limbs, after the angiographic identification of both internal iliac artery (IIA) origins. In the case of a large common iliac artery (18&#8211;24 mm), either the bell bottom technique was used or an IIA overstenting (&gt;24 mm) and landing to the external iliac artery (EIA) was performed. The AUI device was applied in some cases, depending on distal landing zones, surgeon&#8217;s preference and availability of the device, especially during the earlier experience [<xref rid="B11-jcm-13-05601" ref-type="bibr">11</xref>]. For patients managed with the AUI device, an iliac occluder was deployed to the contralateral iliac artery, and a femoral&#8211;femoral bypass was performed using a synthetic 8 mm graft (W. L. Gore &amp; Associates, Flagstaff, AZ, USA). Uncomplicated cases were post-operatively transferred to the ward for at least 24 h.</p><p>If an uneventful post-operative course occurred, the patients were discharged the 2nd or 3rd post-operative day, with a re-evaluation at 1, 6, 12 months and yearly thereafter. The 1- and 12-month evaluations were performed using a CTA, depending on the patient&#8217;s renal function [<xref rid="B12-jcm-13-05601" ref-type="bibr">12</xref>]. Duplex ultrasonography was preferred for the 6-month evaluation and the yearly follow-up after 12 months. The imaging protocol could present alterations depending on imaging findings, the presence of endoleak and the patient&#8217;s symptoms.</p></sec><sec id="sec2dot3-jcm-13-05601"><title>2.3. Exclusion Criteria</title><p>Patients managed with the Endurant platform or components (e.g., limbs or cuffs) combined with other devices (e.g., main aortic grafts, iliac branched devices) were excluded. Adjunctive procedures decided according to the intra-operative imaging, such as the use of cuffs, endoanchors or a kissing stent of the iliac limbs were not considered as a criterion for exclusion. Patients scheduled for an endovascular repair with the Endurant endograft, needing the inclusion of visceral vessels, using the parallel graft technique, were omitted. Patients managed under urgent circumstances including ruptured or symptomatic AAAs were also excluded.</p></sec><sec id="sec2dot4-jcm-13-05601"><title>2.4. Device and Technical Details</title><p>The bifurcated Endurant II/IIs device was used in all cases. Regarding the Endurant characteristics, the stents are M-shaped, made of nitinol and sewn to a polyester fabric graft while proximal sealing is secured with active suprarenal fixation, having barbs in the suprarenal stent. According to the device&#8217;s instructions for use (IFU), a neck of 15 mm associated with an infra-renal angle &lt;75 and non-severe thrombus or atheroma is needed. In case the neck angle is &lt;60, a neck length of 10 mm is also considered adequate for Endurant&#8217;s deployment. The bifurcated body requires one or two iliac extensions, and a common iliac artery up to 24 mm is considered manageable with the Endurant&#8217;s larger distal limb of 28 mm. The delivery system is sheath-less, with a profile of up to 20 Fr for the main body, meaning that an iliac diameter of at least 7 mm is needed for safe main device advancement.</p></sec><sec id="sec2dot5-jcm-13-05601"><title>2.5. Data Collection</title><p>A dedicated database was created for the collection of pre-, intra- and post-operative data, which were inserted after pseudonymization by an experienced study nurse and vascular surgeons. Clinical and imaging data of any follow-up evaluation were added to the same database. Patients who did not attend the scheduled follow-up with evaluation at least once per two years, after the index procedure, were considered as lost to follow-up.</p></sec><sec id="sec2dot6-jcm-13-05601"><title>2.6. Definitions</title><p>The infra-renal diameter was considered the outer&#8211;outer wall diameter of the aorta just below the inferior main renal artery [<xref rid="B13-jcm-13-05601" ref-type="bibr">13</xref>]. Neck thrombus and calcification were expressed as percentages of the aortic circumference, with 0&#8211;25% considered as mild, 25&#8211;50% as moderate and &gt;50% as severe [<xref rid="B14-jcm-13-05601" ref-type="bibr">14</xref>]. The presence of calcification/thrombus in &gt;50% of vessel length was reported as severe iliac thrombus or calcification [<xref rid="B15-jcm-13-05601" ref-type="bibr">15</xref>]. A diameter of the CIA over 18 mm was used to identify an aneurysmal CIA [<xref rid="B16-jcm-13-05601" ref-type="bibr">16</xref>]. Technical success and major systemic complications (MSCs) were reported according to the Society of Vascular Surgery Reporting Standards for endovascular aortic aneurysm repair [<xref rid="B17-jcm-13-05601" ref-type="bibr">17</xref>]. According to the Society of Vascular Surgery guidelines, the device oversizing at the level of the infra-renal neck should be 10&#8211;20% [<xref rid="B18-jcm-13-05601" ref-type="bibr">18</xref>,<xref rid="B19-jcm-13-05601" ref-type="bibr">19</xref>]. The oversizing was calculated according to the average neck diameter throughout the intended sealing zone [<xref rid="B18-jcm-13-05601" ref-type="bibr">18</xref>,<xref rid="B19-jcm-13-05601" ref-type="bibr">19</xref>].</p></sec><sec id="sec2dot7-jcm-13-05601"><title>2.7. Outcomes</title><p>Primary outcomes were the technical success, mortality and MSC rates at 30 days. Survival, freedom from endoleak types I and IIIa and freedom from reintervention during long-term follow-up were considered secondary outcomes.</p></sec><sec id="sec2dot8-jcm-13-05601"><title>2.8. Statistical Analysis</title><p>Normally distributed continuous data were reported as mean&#8211;standard deviation, and non-normally distributed as median values with range and IQR. Categorical data were expressed as absolute numbers and percentages. The chi-square test was used for categorical data comparison. Independent two-sample t tests were used for normally distributed continuous variables, and the Mann&#8211;Whitney U test for non-normally distributed continuous and ordinal variables. Due to the lack of adverse events in the early post-operative period, factors affecting outcomes could not be reliably controlled using regression analysis according to the rule of thumb. Kaplan&#8211;Meier estimates were performed to assess follow-up outcomes. To determine risk-adjusted follow-up outcomes, Cox proportional hazards models were employed, adjusting for known variables, as they were detected previously in the literature: neck diameter and length, conformity to IFU and oversizing. No correction for multiple hypothesis testing was applied. The sample size was allowed to vary based on the analysis, and no imputation of missing data was performed as missing data were infrequent (&lt;5%) for both categorical and continuous variables. The <italic toggle="yes">p</italic> value was considered significant when it was &lt;0.05 (two-tailed hypothesis). Statistical analysis was performed by SPSS 29.0 for Windows software (IBM Corp, Armonk, NY, USA)</p></sec></sec><sec sec-type="results" id="sec3-jcm-13-05601"><title>3. Results</title><sec id="sec3dot1-jcm-13-05601"><title>3.1. Patients&#8217; Cohort</title><p>From 2008 to 2024, 361 patients were treated electively with standard EVAR using the Medtronic II/IIs stent graft in a single tertiary center. The mean age was 72.7 &#177; 7 (52&#8211;92) years, and 96% (347/361) were males. The mean AAA diameter was 62 &#177; 14 mm. Patients&#8217; comorbidities are presented in <xref rid="jcm-13-05601-t001" ref-type="table">Table 1</xref>.</p><p>Most patients were treated with a bifurcated device (92%; 332/361), and 89% (324/361) of the patients were treated according to the IFUs of the device. Pre-operative anatomic characteristics of the aorta and the iliac arteries are shown in <xref rid="jcm-13-05601-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec3dot2-jcm-13-05601"><title>3.2. Intra-Operative Findings</title><p>Epidural or local anesthesia was chosen for 53% (193/361) of patients, while 47% of the patients (168/361) were treated under general anesthesia. The technical success rate was 99.7% (360/361); in one patient, an open conversion was needed. In 42 (11.6%) patients (in three, bilaterally), at least one internal iliac artery was overstented, and landing to the EIA was chosen. Intra-operative unscheduled adjunctive procedures included 15 patients with proximal cuff deployment and 6 patients with endoanchor treatment; all endoanchors were applied in cases with a type Ia endoleak shown in the completion angiography, while the use of cuffs was related to intra-operative caudal device migration, with or without the presence of endoleak. The final decision was at the discretion of the treating physician. The mean operative time was 135 &#177; 56 min, and the mean contrast volume was 108 &#177; 101 mL.</p></sec><sec id="sec3dot3-jcm-13-05601"><title>3.3. Early Clinical Outcomes</title><p>The 30-day mortality was 0.6% (2/361). One patient developed multiorgan failure, and one patient died from a cardiac cause. Major complications were recorded in 15 patients (4.1%): 2 (0.5%) patients suffered a myocardial infarction, 5 (1.3%) needed access reintervention, 5 (1.3%) presented with acute limb ischemia and 3 (0.8%) with acute kidney injury (AKI) needing dialysis. The median hospital stay was 4 (IQR 1) days. In 14% of patients, a blood transfusion was needed during hospitalization.</p></sec><sec id="sec3dot4-jcm-13-05601"><title>3.4. Follow-Up Outcomes</title><p>The mean follow-up was 20.9 &#177; 25 months, with 30.4% being lost to follow-up. The survival rate was 93% (SE 2.3%), 81% (SE 4.8%), 72% (SE 6.4%) and 52% (SE 9.2%) at 2, 4, 6 and 8 years, respectively (<xref rid="jcm-13-05601-f001" ref-type="fig">Figure 1</xref>). In total, 32 patients died during follow-up. Six patients presented with ruptured EVAR; four underwent urgent open conversion (two of them survived), and two died without intervention. After Cox regression analysis was performed, defining neck diameter [hazard ratio (HR) 1.1, 95% CI 0.9&#8211;1.3, <italic toggle="yes">p</italic> = 0.08] and IFU (HR 0.2, 95% CI 0.03&#8211;1.2, <italic toggle="yes">p</italic> = 0.08) as co-factors, neither co-factor was shown to affect the long-term survival.</p><p>The freedom from endoleak Ia rate was 99% (SE 0.7%), 94.3% (SE 3.2%) and 76% (SE 7.3%) at 1, 4 and 6 years, respectively (<xref rid="jcm-13-05601-f002" ref-type="fig">Figure 2</xref>). After Cox regression analysis was performed, defining oversizing rate (HR 3.15, 95% CI 0.4&#8211;23.5, <italic toggle="yes">p</italic> = 0.26), neck length (HR 1.1, 95% CI 0.19&#8211;6.4, <italic toggle="yes">p</italic> = 0.9) and neck diameter (HR 1.12, 95% CI 0.9&#8211;1.39, <italic toggle="yes">p</italic> = 0.28) as co-factors, none of the co-factors was shown to affect endoleak Ia.</p><p>The estimated freedom from endoleak type Ib was 99.2% (SE 0.6%), 92% (SE 3.5%) and 79% (SE 7.4%) at 1, 4 and 7 years, respectively (<xref rid="jcm-13-05601-f003" ref-type="fig">Figure 3</xref>), with no event recorded during the 1st-month follow-up. After Cox regression analysis was performed, defining IFU (HR 0.7, 95% CI 0.04&#8211;11,7 <italic toggle="yes">p</italic> = 0.07) as a co-factor, no impact on endoleak type Ib was detected. No patient with CIA diameter &gt;18 mm presented an endoleak type Ib.</p><p>The freedom from endoleak type III was 97% (SE 2.3%) and 94% (SE 3.7%) at 4 and 5 years, respectively (<xref rid="jcm-13-05601-f004" ref-type="fig">Figure 4</xref>), while one more patient presented with an ET III at 120 months of follow-up. After Cox regression analysis was performed, defining IFU (HR 25.1 95% CI 0.00&#8211;22489 <italic toggle="yes">p</italic> = 0.58) as a co-factor, no impact was detected.</p><p>The freedom from any high-flow endoleak (type Ia, Ib and III) was 98% (SE 0.8%), 93% (SE 2.9%), 73% (SE 6.7%) and 60% (SE 8.1%) at 1, 3, 5 and 7 years, respectively (<xref rid="jcm-13-05601-f005" ref-type="fig">Figure 5</xref>). Regarding endoleak type II, the estimated freedom from endoleak type II rate was 75% (SE 3.2%) at 36 months of follow-up.</p><p>Freedom from reintervention rate was 92% (SE 1.7%), 86.4% (SE 3.2%), 71% (SE 6.1%) and 55% (SE 7.9%) at 1, 3, 5 and 7 years, respectively (<xref rid="jcm-13-05601-f006" ref-type="fig">Figure 6</xref>). After Cox regression analysis was performed, defining Endoleak type II as a potential parameter for reintervention, no significance was detected (HR 1.53 95% CI 0.7&#8211;3.35 <italic toggle="yes">p</italic> = 0.21). In total, 41 patients received 54 reinterventions, as depicted in <xref rid="jcm-13-05601-t003" ref-type="table">Table 3</xref>. In addition to high-flow endoleak management, one patient was managed for graft infection and one for an aortoenteric fistula with severe bleeding, while two patients presented with total graft thrombosis. Iliac limb occlusion affected eleven patients, while three patients presented iliac limb stenosis and were treated preventively.</p></sec></sec><sec sec-type="discussion" id="sec4-jcm-13-05601"><title>4. Discussion</title><p>The Endurant endograft has been related to promising long-term outcomes at 8 years of follow-up, with freedom from aneurysm rupture at 95% and freedom from endoleak I/III at 87.3% [<xref rid="B7-jcm-13-05601" ref-type="bibr">7</xref>]. However, the published literature reporting data over five years of follow-up is quite limited [<xref rid="B6-jcm-13-05601" ref-type="bibr">6</xref>,<xref rid="B7-jcm-13-05601" ref-type="bibr">7</xref>]. The current analysis including real-world experience data showed a 72% and 52% survival at 6 and 8 years of follow-up, respectively, with very low aneurysm-related mortality, freedom from high-flow endoleaks at 60% at 7 years and freedom from reintervention at 55% at 7 years. The early outcomes, including technical success, mortality and major complications, once again confirmed the safety of the Endurant endograft, as also previously described in the ENGAGE registry [<xref rid="B20-jcm-13-05601" ref-type="bibr">20</xref>]. Early EVAR safety has been previously confirmed and allowed it to be established as the first-line treatment in patients with appropriate anatomy [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>]. However, long-term endoleak formation and the associated high rate of reintervention set still the durability of the technique in disguise [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>,<xref rid="B21-jcm-13-05601" ref-type="bibr">21</xref>].</p><p>The recent guidelines of the ESVS suggest the use of EVAR, as first-line treatment, in appropriately selected patients while they highlight the role of adequate device selection relying not only on the patient&#8217;s anatomy but further on the long-term durability outcomes of the devices, as reported in the literature [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>]. In addition, the recent guidelines advise the use of the devices according to the specific IFU, as defined by each manufacturer [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>]. However, the previously published experience is rather conflicting regarding the impact of IFUs in real-world studies [<xref rid="B22-jcm-13-05601" ref-type="bibr">22</xref>,<xref rid="B23-jcm-13-05601" ref-type="bibr">23</xref>]. In our analysis, IFU was not detected as a predictor of adverse events after it was included as a co-factor in the Cox regression analyses [<xref rid="B24-jcm-13-05601" ref-type="bibr">24</xref>].</p><p>Regarding the early outcomes, including technical success, mortality and major complications, Endurant performed with very high safety, as detected by the associated rates and the sporadic adverse events. The early and midterm outcomes of the EAGLE registry confirmed that, even when applied in challenging anatomies, Endurant can provide a high technical success rate and low aneurysm-related mortality [<xref rid="B25-jcm-13-05601" ref-type="bibr">25</xref>]. As early findings seem to affect long-term outcomes, in terms of survival, need for reintervention and risk of aneurysm rupture, initial technical success seems of major importance [<xref rid="B26-jcm-13-05601" ref-type="bibr">26</xref>]. In this analysis, 5.8% of patients needed an additional intra-operative maneuver to secure the proximal sealing zone. Adjunctive procedures, such as the use of aortic cuffs or endoanchors, when needed, should be performed to increase the stability of the device in the proximal sealing zone [<xref rid="B27-jcm-13-05601" ref-type="bibr">27</xref>].</p><p>The survival was estimated at 72% and 52% at 6 and 8 years, respectively, in the current cohort. However, only six events of aneurysm-related mortality were detected, showing that the long-term survival may be affected by other underlying diseases and parameters. Previous meta-analytic data seem to confirm this steep decrease in survival when passing from the mid-term to long-term follow-up and relate this finding to the aneurysm-related mortality, a pattern that does not seem to be confirmed in the current analysis [<xref rid="B21-jcm-13-05601" ref-type="bibr">21</xref>]. Patient age and underlying comorbidities seem to affect significantly the long-term outcomes of EVAR in an elective setting, with older and multimorbid patients being at higher mortality risk [<xref rid="B28-jcm-13-05601" ref-type="bibr">28</xref>]. In our cohort, coronary artery disease was the third most common comorbidity, affecting 40% of patients and potentially affecting long-term survival [<xref rid="B29-jcm-13-05601" ref-type="bibr">29</xref>]. In addition, the use of Endurant out of the IFU and in large necks did not affect outcomes, despite previous studies showing that both factors may play a significant role in survival [<xref rid="B22-jcm-13-05601" ref-type="bibr">22</xref>,<xref rid="B30-jcm-13-05601" ref-type="bibr">30</xref>].</p><p>High-flow endoleaks were detected in almost 30% of patients at 7 years of follow-up, with type Ia being detected in 25% of them during the same period. Supra-renal fixation may be related to proximal aortic dilation during the mid-term follow-up and potentially lead to endoleak formation during the long-term surveillance, highlighting the potential necessity of using endoanchors primarily to prevent neck dilatation after EVAR. [<xref rid="B12-jcm-13-05601" ref-type="bibr">12</xref>,<xref rid="B31-jcm-13-05601" ref-type="bibr">31</xref>,<xref rid="B32-jcm-13-05601" ref-type="bibr">32</xref>]. Available Endurant long-term data showed similar to the current analysis rates of endoleak type I/III at 8 and 10 years of follow-up, while the application of Endurant out of the IFU has been detected as an independent predictor for high-flow endoleaks [<xref rid="B7-jcm-13-05601" ref-type="bibr">7</xref>,<xref rid="B21-jcm-13-05601" ref-type="bibr">21</xref>]. Type II endoleaks were not further investigated in this study, due to their multifactorial nature [<xref rid="B1-jcm-13-05601" ref-type="bibr">1</xref>]. However, previous studies showed that device material may affect endoleak type II formation up to 2 years of follow-up [<xref rid="B33-jcm-13-05601" ref-type="bibr">33</xref>,<xref rid="B34-jcm-13-05601" ref-type="bibr">34</xref>]. Anatomic parameters, including large proximal neck and iliac diameters, and application of the device out of the IFU did not provide significance in Cox regression analyses of endoleaks, showing that the device can provide safety even in unfriendly anatomies [<xref rid="B22-jcm-13-05601" ref-type="bibr">22</xref>,<xref rid="B30-jcm-13-05601" ref-type="bibr">30</xref>].</p><p>Regarding reinterventions, less than half of patients needed a secondary intervention during the long-term follow-up. However, it should be noted that most reinterventions were performed in 41 patients; most of them were treated during the 1st year and 50% of them were related to distal sealing or patency complications and were relatively minor ones [<xref rid="B7-jcm-13-05601" ref-type="bibr">7</xref>]. The limb occlusion rate has been reported at 5% during the mid-term follow-up, while loss of distal sealing seems to affect almost 20% of patients and has been previously related to dilated distal sealing zones [<xref rid="B16-jcm-13-05601" ref-type="bibr">16</xref>,<xref rid="B31-jcm-13-05601" ref-type="bibr">31</xref>]. Except for the four open conversions, all complications related to the proximal sealing zone were resolved using endovascular means [<xref rid="B21-jcm-13-05601" ref-type="bibr">21</xref>]. Open conversion after failed EVAR has been related to high mortality rates, especially when patients present with ruptured AAAs [<xref rid="B35-jcm-13-05601" ref-type="bibr">35</xref>]. On the other hand, endovascular management with fenestrated or branched devices after failed EVAR has been related to 2.4% mortality and high technical success when performed by experienced hands [<xref rid="B36-jcm-13-05601" ref-type="bibr">36</xref>]. Especially regarding the secondary endovascular management of a failed Endurant graft, the presence of the wide diameter bare stent, despite challenges, permits the catheterization of the visceral vessels and the completion of the procedure in most cases.</p><p>Endurant seems to be a safe solution in the short term according to previous data and the findings of the current analysis [<xref rid="B20-jcm-13-05601" ref-type="bibr">20</xref>]. The presence of highly visible markers, the ease of device deployment and the conformity of the device even in extreme proximal angulations make the Endurant an attractive solution. The long-term data follow the literature on general EVAR performance, with a high need for reinterventions during the long-term follow-up [<xref rid="B37-jcm-13-05601" ref-type="bibr">37</xref>]. The long-term survival may seem discouraging, but it should be noted that EVAR is still performed in elder patients with high-risk profiles. However, the aneurysm-related mortality remains low, showing that Endurant is a durable and reliable solution for elective AAA management, even when applied out of IFU and in hostile neck anatomies, while further investigations on the use of endoanchors, even in non-hostile necks, may be able to decrease significantly the presence of proximal endoleaks and reinterventions [<xref rid="B27-jcm-13-05601" ref-type="bibr">27</xref>,<xref rid="B38-jcm-13-05601" ref-type="bibr">38</xref>,<xref rid="B39-jcm-13-05601" ref-type="bibr">39</xref>]. The Cox regression analysis failed to confirm any correlation to hostile anatomic factors and rather confirms Endurant&#8217;s reliability but at the same time raises questions about the predictability of EVAR failure, in hostile and non-hostile anatomies, and appropriate surveillance protocols [<xref rid="B40-jcm-13-05601" ref-type="bibr">40</xref>]. Standardized follow-up imaging, in rational time intervals, and using the principle of as little radiation exposure as possible, is important for the prevention and early detection of complications. Social and economic factors, health system facilities and patient&#8217;s needs, though, should be taken into consideration to provide appropriate surveillance.</p><sec><title>Limitations</title><p>The retrospective design of the study and the relatively small sample size may have influenced the findings of the analysis. No comparisons were attempted between the Endurant device and other widely used available devices, while patients who were managed with a combination of devices or received Endurant components (e.g., cuffs, iliac limbs, tube grafts) were excluded from the analysis to increase homogeneity. The latest criterion led to the exclusion of patients managed with iliac branched devices for the preservation of the hypogastric artery, as the Endurant platform does not provide such an endovascular solution. A further investigation of the parameters affecting different types of reinterventions and their etiology was not attempted, as such a subgroup analysis would be significantly underpowered, and the outcomes would not be reliable (rule of thumb). On the other hand, patients with AUI were included and may have affected the findings, especially regarding distal landing zone adverse events and reinterventions, while it should be noted that AUI devices mainly represent the earlier experience of our department. Iliac tortuosity was not analyzed, due to a lack of information, but may have affected outcomes in terms of iliac limb adverse events. Percutaneous access was not employed in any Endurant case, due to bureaucratic reasons only. Patients lost to follow-up may have potentially affected our outcomes and decreased the robustness of our follow-up findings. Although neither neck dilation nor IFU affected our findings, this fact should be interpreted cautiously, as the currently available literature is rather conflicting. Endoleak type II was not investigated in detail, as it is considered a multifactorial phenomenon, whose evolution is affected by anatomic, pharmacological and technical factors, and a direct correlation between Endurant&#8217;s performance and endoleak type II would be difficult to establish.</p></sec></sec><sec sec-type="conclusions" id="sec5-jcm-13-05601"><title>5. Conclusions</title><p>The Endurant II/IIs endograft is a safe and effective elective EVAR solution with excellent early outcomes and very low long-term aneurysm-related mortality. The need for reintervention in the long term affected less than 50% of cases. Type Ia/b endoleaks were encountered in 30% of patients during the long-term follow-up, while type III was less common.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, K.S. and A.G.; methodology, K.S. and P.N.; software, K.S.; validation, K.S., P.N. and G.K.; formal analysis, K.S., P.N., G.V. and K.D.; investigation K.S., P.N., G.V., G.K., K.D. and C.K.; data curation, K.S., P.N., G.V., K.D., G.K., C.K. and E.A.; writing&#8212;original draft preparation, K.S., P.N. and A.G.; writing&#8212;review and editing, K.S., P.N., G.V., G.K., K.D., C.K., E.A., M.M. and A.G.; supervision, A.G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study complied with the Declaration of Helsinki, and ethical approval was waived, given the retrospective design and the use of anonymized data.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data are available upon reasonable request from the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-jcm-13-05601"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wanhainen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Van Herzeele</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bastos Goncalves</surname><given-names>F.</given-names></name><name name-style="western"><surname>Belmout Montoya</surname><given-names>S.</given-names></name><name name-style="western"><surname>Berard</surname><given-names>X.</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>D&#8217;Oria</surname><given-names>M.</given-names></name><name name-style="western"><surname>Prendes</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Karkos</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Kazimierczak</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Editor&#8217;s Choice&#8212;European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2024</year><volume>67</volume><fpage>192</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">38307694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejvs.2023.11.002</pub-id></element-citation></ref><ref id="B2-jcm-13-05601"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krisna Pertiwi</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Sudarma</surname><given-names>I.W.</given-names></name><name name-style="western"><surname>Prana Jagannatha</surname><given-names>G.N.</given-names></name><name name-style="western"><surname>Kosasih</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Dyah Yustika Dewi</surname><given-names>C.I.</given-names></name><name name-style="western"><surname>Angga Wijaya</surname><given-names>I.G.A.</given-names></name></person-group><article-title>Outcomes of advanced EVAR versus open surgery in the management of complex abdominal aortic aneurysm repair: A systematic review and meta-analysis</article-title><source>Asian Cardiovasc. Thorac. Ann.</source><year>2024</year><comment><italic toggle="yes">Online ahead of print</italic></comment><pub-id pub-id-type="doi">10.1177/02184923241262847</pub-id><pub-id pub-id-type="pmid">38887046</pub-id></element-citation></ref><ref id="B3-jcm-13-05601"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yei</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mathlouthi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Naazie</surname><given-names>I.</given-names></name><name name-style="western"><surname>Elsayed</surname><given-names>N.</given-names></name><name name-style="western"><surname>Clary</surname><given-names>B.</given-names></name><name name-style="western"><surname>Malas</surname><given-names>M.</given-names></name></person-group><article-title>Long-term Outcomes Associated with Open vs Endovascular Abdominal Aortic Aneurysm Repair in a Medicare-Matched Database</article-title><source>JAMA Netw. Open.</source><year>2022</year><volume>5</volume><fpage>e2212081</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.12081</pub-id><pub-id pub-id-type="pmid">35560049</pub-id><pub-id pub-id-type="pmcid">PMC9107027</pub-id></element-citation></ref><ref id="B4-jcm-13-05601"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kanzafarova</surname><given-names>I.</given-names></name><name name-style="western"><surname>Yonkus</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Colglazier</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Shuja</surname><given-names>F.</given-names></name><name name-style="western"><surname>DeMartino</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Kalra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>T.E.</given-names></name></person-group><article-title>Clinical presentation, operative management, and long-term outcomes of rupture after previous abdominal aortic aneurysm repair</article-title><source>J. Vasc. Surg.</source><year>2023</year><volume>77</volume><fpage>396</fpage><lpage>405.e7</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2022.08.005</pub-id><pub-id pub-id-type="pmid">36272507</pub-id></element-citation></ref><ref id="B5-jcm-13-05601"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teijink</surname><given-names>J.A.W.</given-names></name><name name-style="western"><surname>Power</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>B&#246;ckler</surname><given-names>D.</given-names></name><name name-style="western"><surname>Peeters</surname><given-names>P.</given-names></name><name name-style="western"><surname>van Sterkenburg</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bouwman</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Verhagen</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Bosiers</surname><given-names>M.</given-names></name><name name-style="western"><surname>Riambau</surname><given-names>V.</given-names></name><name name-style="western"><surname>Becquemin</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Editor&#8217;s Choice&#8212;Five Year Outcomes of the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair in the ENGAGE Registry</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2019</year><volume>58</volume><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2019.01.008</pub-id><pub-id pub-id-type="pmid">31235305</pub-id></element-citation></ref><ref id="B6-jcm-13-05601"><label>6.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Verhagen</surname><given-names>H.</given-names></name></person-group><article-title>The ENGAGE Registry: Ten-Year Outcomes with the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair</article-title><source>Proceedings of the Charing Cross 2023 International Symposium</source><conf-loc>London, UK</conf-loc><conf-date>26 April 2023</conf-date><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://news.medtronic.com/10-Year-Data-from-the-Medtronic-ENGAGE-OUS-Registry-is-the-First-and-Only-Prospective,-Industry-Sponsored-Global-EVAR-Registry-to-Demonstrate-a-Decade-of-Durable-Outcomes-in-Real-World-Setting" ext-link-type="uri">https://news.medtronic.com/10-Year-Data-from-the-Medtronic-ENGAGE-OUS-Registry-is-the-First-and-Only-Prospective,-Industry-Sponsored-Global-EVAR-Registry-to-Demonstrate-a-Decade-of-Durable-Outcomes-in-Real-World-Setting</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-08-17">(accessed on 17 August 2024)</date-in-citation></element-citation></ref><ref id="B7-jcm-13-05601"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Georgiadis</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Schoretsanitis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Argyriou</surname><given-names>C.</given-names></name><name name-style="western"><surname>Nikolopoulos</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kapoulas</surname><given-names>K.</given-names></name><name name-style="western"><surname>Georgakarakos</surname><given-names>E.I.</given-names></name><name name-style="western"><surname>Ktenidis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lazarides</surname><given-names>M.K.</given-names></name></person-group><article-title>Long-term outcomes of the Endurant endograft in patients undergoing endovascular abdominal aortic aneurysm repair</article-title><source>J. Vasc. Surg.</source><year>2023</year><volume>78</volume><fpage>668</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2023.04.033</pub-id><pub-id pub-id-type="pmid">37141949</pub-id></element-citation></ref><ref id="B8-jcm-13-05601"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Elm</surname><given-names>E.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Egger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pocock</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>G&#248;tzsche</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Vandenbroucke</surname><given-names>J.P.</given-names></name><collab>STROBE Initiative</collab></person-group><article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies</article-title><source>Int. J. Surg.</source><year>2014</year><volume>12</volume><fpage>1495</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2014.07.013</pub-id><pub-id pub-id-type="pmid">25046131</pub-id></element-citation></ref><ref id="B9-jcm-13-05601"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moll</surname><given-names>F.L.</given-names></name><name name-style="western"><surname>Powell</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Fraedrich</surname><given-names>G.</given-names></name><name name-style="western"><surname>Verzini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Haulon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Waltham</surname><given-names>M.</given-names></name><name name-style="western"><surname>van Herwaarden</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Holt</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>van Keulen</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Rantner</surname><given-names>B.</given-names></name><etal/></person-group><article-title>European Society for Vascular Surgery. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2011</year><volume>41</volume><issue>(Suppl. S1)</issue><fpage>S1</fpage><lpage>S58</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2010.09.011</pub-id><pub-id pub-id-type="pmid">21215940</pub-id></element-citation></ref><ref id="B10-jcm-13-05601"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wanhainen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Verzini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Van Herzeele</surname><given-names>I.</given-names></name><name name-style="western"><surname>Allaire</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bown</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cohnert</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dick</surname><given-names>F.</given-names></name><name name-style="western"><surname>van Herwaarden</surname><given-names>J.</given-names></name><name name-style="western"><surname>Karkos</surname><given-names>C.</given-names></name><name name-style="western"><surname>Koelemay</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Editor&#8217;s Choice&#8212;European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2019</year><volume>57</volume><fpage>8</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2018.09.020</pub-id><pub-id pub-id-type="pmid">30528142</pub-id></element-citation></ref><ref id="B11-jcm-13-05601"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pursa</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Nolz</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wibmer</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Schoder</surname><given-names>M.</given-names></name><name name-style="western"><surname>Teufelsbauer</surname><given-names>H.</given-names></name></person-group><article-title>Rates of adverse events and correction procedures after elective versus emergent aortouni-iliac endografting during mid-term follow-up: A prospective cohort study</article-title><source>Int. J. Surg.</source><year>2015</year><volume>18</volume><fpage>104</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2015.04.038</pub-id><pub-id pub-id-type="pmid">25900599</pub-id></element-citation></ref><ref id="B12-jcm-13-05601"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kouvelos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Spanos</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mpatzalexis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Arnaoutoglou</surname><given-names>E.</given-names></name><name name-style="western"><surname>Giannoukas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Matsagkas</surname><given-names>M.</given-names></name></person-group><article-title>Risk factors and adverse events related to supra- and infra-renal aortic dilation at twelve months after endovascular abdominal aortic aneurysm repair</article-title><source>Int. Angiol.</source><year>2022</year><volume>41</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.23736/S0392-9590.22.04971-9</pub-id><pub-id pub-id-type="pmid">36507796</pub-id></element-citation></ref><ref id="B13-jcm-13-05601"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sternbergh</surname><given-names>W.C.</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Money</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Chuter</surname><given-names>T.A.</given-names></name><collab>Zenith Investigators</collab></person-group><article-title>Influence of endograft oversizing on device migration, endoleak, aneurysm shrinkage, and aortic neck dilation: Results from the Zenith Multicenter Trial</article-title><source>J. Vasc. Surg.</source><year>2004</year><volume>39</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2003.09.022</pub-id><pub-id pub-id-type="pmid">14718806</pub-id></element-citation></ref><ref id="B14-jcm-13-05601"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jordan</surname><given-names>W.D.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Ouriel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Varnagy</surname><given-names>D.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>W.M.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Arko</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Joye</surname><given-names>J.</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>J.P.</given-names></name></person-group><article-title>Aneurysm Treatment using the Heli-FX Aortic Securement System Global Registry ANCHOR; Aneurysm Treatment using the Heli-FX Aortic Securement System Global Registry ANCHOR. Aneurysm Treatment using the Heli-FX Aortic Securement System Global Registry ANCHOR; Aneurysm Treatment using the Heli-FX Aortic Securement System Global Registry ANCHOR. Outcome based anatomic criteria for defining the hostile aortic neck</article-title><source>J. Vasc. Surg.</source><year>2015</year><volume>61</volume><fpage>1383</fpage><lpage>1390.e1</lpage><pub-id pub-id-type="pmid">25735260</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jvs.2014.12.063</pub-id></element-citation></ref><ref id="B15-jcm-13-05601"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaikof</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Fillinger</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Rutherford</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>White</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Blankensteijn</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Bernhard</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Kent</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>May</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair</article-title><source>J. Vasc. Surg.</source><year>2002</year><volume>35</volume><fpage>1061</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1067/mva.2002.123991</pub-id><pub-id pub-id-type="pmid">12021728</pub-id></element-citation></ref><ref id="B16-jcm-13-05601"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Spanos</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kouvelos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dakis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Arnaoutoglou</surname><given-names>E.</given-names></name><name name-style="western"><surname>Giannoukas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Matsagkas</surname><given-names>M.</given-names></name></person-group><article-title>The Impact of Iliac Artery Anatomy on Distal Landing Zone After EVAR during the 12-Month Follow-Up</article-title><source>Ann. Vasc. Surg.</source><year>2023</year><volume>88</volume><fpage>354</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2022.06.011</pub-id><pub-id pub-id-type="pmid">35779805</pub-id></element-citation></ref><ref id="B17-jcm-13-05601"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaikof</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Blankensteijn</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>White</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Zarins</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Bernhard</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>May</surname><given-names>J.</given-names></name><name name-style="western"><surname>Veith</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Fillinger</surname><given-names>M.F.</given-names></name><etal/></person-group><article-title>Reporting standards for endovascular aortic aneurysm repair</article-title><source>J. Vasc. Surg.</source><year>2002</year><volume>35</volume><fpage>1048</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1067/mva.2002.123763</pub-id><pub-id pub-id-type="pmid">12021727</pub-id></element-citation></ref><ref id="B18-jcm-13-05601"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaikof</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Dalman</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Eskandari</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Anthony Lee</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ashraf Mansour</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mastracci</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Mell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hassan Murad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>L.L.</given-names></name><etal/></person-group><article-title>The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm</article-title><source>J. Vasc. Surg.</source><year>2018</year><volume>67</volume><fpage>2</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2017.10.044</pub-id><pub-id pub-id-type="pmid">29268916</pub-id></element-citation></ref><ref id="B19-jcm-13-05601"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Spanos</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kouvelos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dakis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Arnaoutoglou</surname><given-names>E.</given-names></name><name name-style="western"><surname>Giannoukas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Matsagkas</surname><given-names>M.</given-names></name></person-group><article-title>Conical Aortic Neck as a Predictor of Outcome after Endovascular Aneurysm Exclusion: Midterm Results</article-title><source>Ann. Vasc. Surg.</source><year>2023</year><volume>90</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2022.11.004</pub-id><pub-id pub-id-type="pmid">36460173</pub-id></element-citation></ref><ref id="B20-jcm-13-05601"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stokmans</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Teijink</surname><given-names>J.A.W.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>B&#246;ckler</surname><given-names>D.</given-names></name><name name-style="western"><surname>Peeters</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Riambau</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>van Sambeek</surname><given-names>M.R.</given-names></name></person-group><article-title>Early results from the ENGAGE registry: Real-world performance of the Endurant Stent Graft for endovascular AAA repair in 1262 patients</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2012</year><volume>44</volume><fpage>369</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2012.07.005</pub-id><pub-id pub-id-type="pmid">22835762</pub-id></element-citation></ref><ref id="B21-jcm-13-05601"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antoniou</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Antoniou</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Torella</surname><given-names>F.</given-names></name></person-group><article-title>Editor&#8217;s Choice&#8212;Endovascular vs. Open Repair. for Abdominal Aortic Aneurysm: Systematic Review and Meta-analysis of Updated Peri-operative and Long Term Data of Randomised Controlled Trials</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2020</year><volume>59</volume><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2019.11.030</pub-id><pub-id pub-id-type="pmid">31899100</pub-id></element-citation></ref><ref id="B22-jcm-13-05601"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Accarino</surname><given-names>G.</given-names></name><name name-style="western"><surname>De Vuono</surname><given-names>F.</given-names></name><name name-style="western"><surname>Accarino</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fornino</surname><given-names>G.</given-names></name><name name-style="western"><surname>Puca</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Fimiani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Parrella</surname><given-names>V.</given-names></name><name name-style="western"><surname>Savarese</surname><given-names>G.</given-names></name><name name-style="western"><surname>Furgiuele</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vecchione</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Endurant Stent Graft for Treatment of Abdominal Aortic Aneurysm Inside and Outside of the Instructions for Use for the Proximal Neck: A 14-Year, Single-Center Experience</article-title><source>J. Clin. Med.</source><year>2024</year><volume>13</volume><elocation-id>2589</elocation-id><pub-id pub-id-type="doi">10.3390/jcm13092589</pub-id><pub-id pub-id-type="pmid">38731118</pub-id><pub-id pub-id-type="pmcid">PMC11084245</pub-id></element-citation></ref><ref id="B23-jcm-13-05601"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mwipatayi</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Farai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Oshin</surname><given-names>O.</given-names></name><name name-style="western"><surname>Fitridge</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schermerhorn</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Becquemin</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Boeckler</surname><given-names>D.</given-names></name><name name-style="western"><surname>Riambau</surname><given-names>V.</given-names></name><name name-style="western"><surname>Teijink</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Endurant stent graft demonstrates promising outcomes in challenging abdominal aortic aneurysm anatomy</article-title><source>J. Vasc. Surg.</source><year>2021</year><volume>73</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2020.04.508</pub-id><pub-id pub-id-type="pmid">32442605</pub-id></element-citation></ref><ref id="B24-jcm-13-05601"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#214;zdemir-van Brunschot</surname><given-names>D.M.D.</given-names></name><name name-style="western"><surname>Holzhey</surname><given-names>D.</given-names></name><name name-style="western"><surname>Botsios</surname><given-names>S.</given-names></name></person-group><article-title>Mid-term results of &#8220;off-label&#8221; use of the Endurant stentgraft in patients with infrarenal abdominal aortic aneurysms</article-title><source>Vascular</source><year>2024</year><comment><italic toggle="yes">Online ahead of print</italic></comment><pub-id pub-id-type="doi">10.1177/17085381241247265</pub-id><pub-id pub-id-type="pmid">38606774</pub-id></element-citation></ref><ref id="B25-jcm-13-05601"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Basten Batenburg</surname><given-names>M.</given-names></name><name name-style="western"><surname>W&#8217;t Mannetje</surname><given-names>Y.</given-names></name><name name-style="western"><surname>van Sambeek</surname><given-names>M.R.H.M.</given-names></name><name name-style="western"><surname>Cuypers</surname><given-names>P.W.M.</given-names></name><name name-style="western"><surname>Georgiadis</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Sondakh</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Teijink</surname><given-names>J.A.W.</given-names></name><collab>EAGLE registry collaborators</collab></person-group><article-title>Editor&#8217;s Choice&#8212;Endurant Stent Graft in Patients with Challenging Neck Anatomy One Step Outside Instructions for Use: Early and Midterm Results from the EAGLE Registry</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2022</year><volume>64</volume><fpage>611</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2022.08.002</pub-id><pub-id pub-id-type="pmid">35987507</pub-id></element-citation></ref><ref id="B26-jcm-13-05601"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>de Guerre</surname><given-names>L.E.V.M.</given-names></name><name name-style="western"><surname>Dansey</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Malas</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Schermerhorn</surname><given-names>M.L.</given-names></name></person-group><article-title>The impact of completion and follow-up endoleaks on survival, reintervention, and rupture</article-title><source>J. Vasc. Surg.</source><year>2023</year><volume>77</volume><fpage>1676</fpage><lpage>1684</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2023.02.009</pub-id><pub-id pub-id-type="pmid">36841312</pub-id><pub-id pub-id-type="pmcid">PMC10213115</pub-id></element-citation></ref><ref id="B27-jcm-13-05601"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arko</surname><given-names>F.R.</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Pearce</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Henretta</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Fugate</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Torsello</surname><given-names>G.</given-names></name><name name-style="western"><surname>Panneton</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Edward Garrett</surname><given-names>H.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Five-year outcomes of endosuture aneurysm repair in patients with short neck abdominal aortic aneurysm from the ANCHOR registry</article-title><source>J. Vasc. Surg.</source><year>2023</year><volume>78</volume><fpage>1418</fpage><lpage>1425.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2023.07.058</pub-id><pub-id pub-id-type="pmid">37558144</pub-id></element-citation></ref><ref id="B28-jcm-13-05601"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vicario-Feliciano</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zil-E-Ali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aziz</surname><given-names>F.</given-names></name></person-group><article-title>Beta Blockers are Associated with Increased Mortality without a Decrease in Reinterventions after Endovascular Abdominal Aortic Repair (EVAR)</article-title><source>Ann. Vasc. Surg.</source><year>2024</year><comment><italic toggle="yes">Online ahead of print</italic></comment><pub-id pub-id-type="doi">10.1016/j.avsg.2024.07.104</pub-id><pub-id pub-id-type="pmid">39103012</pub-id></element-citation></ref><ref id="B29-jcm-13-05601"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ra&#353;iov&#225;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ko&#353;&#269;o</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pavl&#237;kov&#225;</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hud&#225;k</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mo&#353;&#269;ovi&#269;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ko&#269;an</surname><given-names>L.</given-names></name></person-group><article-title>Predictors of overall mortality after endovascular abdominal aortic repair&#8212;A single centre study</article-title><source>Vascular</source><year>2024</year><comment><italic toggle="yes">Online ahead of print</italic></comment><pub-id pub-id-type="doi">10.1177/17085381241262350</pub-id><pub-id pub-id-type="pmid">38872254</pub-id></element-citation></ref><ref id="B30-jcm-13-05601"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kouvelos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Spanos</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Koutsias</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rousas</surname><given-names>N.</given-names></name><name name-style="western"><surname>Giannoukas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Matsagkas</surname><given-names>M.</given-names></name></person-group><article-title>Large Diameter (&#8805;29 mm) Proximal Aortic Necks Are Associated with Increased Complication Rates after Endovascular Repair for Abdominal Aortic Aneurysm</article-title><source>Ann. Vasc. Sur.</source><year>2019</year><volume>60</volume><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2019.02.031</pub-id><pub-id pub-id-type="pmid">31075483</pub-id></element-citation></ref><ref id="B31-jcm-13-05601"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soares</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Amaro</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nasser</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Cury</surname><given-names>M.V.M.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Pedrosa</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Sacilotto</surname><given-names>R.</given-names></name></person-group><article-title>Endovascular repair for infra-renal aortic aneurysms with supra-renal fixation endoprosthesis: Results and outcomes</article-title><source>Vascular</source><year>2024</year><comment><italic toggle="yes">Online ahead of print</italic></comment><pub-id pub-id-type="doi">10.1177/17085381241264381</pub-id><pub-id pub-id-type="pmid">39030072</pub-id></element-citation></ref><ref id="B32-jcm-13-05601"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pastor Alconchel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Inaraja P&#233;rez</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Herrando Medrano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garc&#237;a Nieto</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hidalgo Iranzo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Marzo &#193;lvarez</surname><given-names>A.C.</given-names></name></person-group><article-title>Influence Of Proximal Fixation on Aneurysm Neck Evolution After Endovascular Treatment of Infrarenal Aneurysms</article-title><source>Ann. Vasc. Surg.</source><year>2024</year><comment><italic toggle="yes">Online ahead of print</italic></comment><pub-id pub-id-type="doi">10.1016/j.avsg.2024.07.092</pub-id><pub-id pub-id-type="pmid">39098726</pub-id></element-citation></ref><ref id="B33-jcm-13-05601"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>V&#228;&#228;r&#228;m&#228;ki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Uurto</surname><given-names>I.</given-names></name><name name-style="western"><surname>Suominen</surname><given-names>V.</given-names></name></person-group><article-title>Possible implications of device-specific variability in post-endovascular aneurysm repair sac regression and endoleaks for surveillance categorization</article-title><source>J. Vasc. Surg.</source><year>2023</year><volume>78</volume><fpage>1204</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2023.07.001</pub-id><pub-id pub-id-type="pmid">37451372</pub-id></element-citation></ref><ref id="B34-jcm-13-05601"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kouvelos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Spanos</surname><given-names>K.</given-names></name><name name-style="western"><surname>Batzalexis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Arnaoutoglou</surname><given-names>E.</given-names></name><name name-style="western"><surname>Giannoukas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Matsagkas</surname><given-names>M.</given-names></name></person-group><article-title>Abdominal Aortic Aneurysm Sac Alteration Depending on Initial Diameter, Endograft Material, and Presence of Endoleak Type II</article-title><source>EJVES Forum.</source><year>2022</year><volume>54</volume><fpage>45</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.ejvsvf.2021.12.064</pub-id></element-citation></ref><ref id="B35-jcm-13-05601"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moulakakis</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Lazaris</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Georgiadis</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Kakkos</surname><given-names>S.</given-names></name><name name-style="western"><surname>Papavasileiou</surname><given-names>V.G.</given-names></name><name name-style="western"><surname>Antonopoulos</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Papapetrou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Katsikas</surname><given-names>V.</given-names></name><name name-style="western"><surname>Klonaris</surname><given-names>C.</given-names></name><name name-style="western"><surname>Geroulakos</surname><given-names>G.</given-names></name><etal/></person-group><article-title>A Greek Multicentre Study Assessing the Outcome of Late Rupture After Endovascular Abdominal Aortic Aneurysm Repair</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2024</year><volume>67</volume><fpage>756</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2023.12.025</pub-id><pub-id pub-id-type="pmid">38154499</pub-id></element-citation></ref><ref id="B36-jcm-13-05601"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nana</surname><given-names>P.</given-names></name><name name-style="western"><surname>K&#246;lbel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Behrendt</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Kouvelos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Giannoukas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Haulon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Spanos</surname><given-names>K.</given-names></name></person-group><article-title>Systematic review of reintervention with fenestrated or branched devices after failed previous endovascular aortic aneurysm repair</article-title><source>J. Vasc. Surg.</source><year>2023</year><volume>77</volume><fpage>1806</fpage><lpage>1814</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2022.11.037</pub-id><pub-id pub-id-type="pmid">36375726</pub-id></element-citation></ref><ref id="B37-jcm-13-05601"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loufopoulos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tasoudis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Koudounas</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zoupas</surname><given-names>I.</given-names></name><name name-style="western"><surname>Madouros</surname><given-names>N.</given-names></name><name name-style="western"><surname>S&#225;</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Karkos</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Giannopoulos</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tassiopoulos</surname><given-names>A.K.</given-names></name></person-group><article-title>Long-Term Outcomes of Open Versus Endovascular Treatment for Abdominal Aortic Aneurysm: Systematic Review and Meta-Analysis with Reconstructed Time-to-Event Data</article-title><source>J. Endovasc. Ther.</source><year>2023</year><comment><italic toggle="yes">Online ahead of print</italic></comment><pub-id pub-id-type="doi">10.1177/15266028231204805</pub-id><pub-id pub-id-type="pmid">37855415</pub-id></element-citation></ref><ref id="B38-jcm-13-05601"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bequemin</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Haupert</surname><given-names>S.</given-names></name><name name-style="western"><surname>Issam</surname><given-names>F.</given-names></name><name name-style="western"><surname>Dubar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Martelloni</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jousset</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sauguet</surname><given-names>A.</given-names></name></person-group><article-title>Five Year Patient Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in the ENDURANT France Registry</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2021</year><volume>61</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2020.08.034</pub-id><pub-id pub-id-type="pmid">33004284</pub-id></element-citation></ref><ref id="B39-jcm-13-05601"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bordet</surname><given-names>M.</given-names></name><name name-style="western"><surname>Oliny</surname><given-names>A.</given-names></name><name name-style="western"><surname>Miasumu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tresson</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lermusiaux</surname><given-names>P.</given-names></name><name name-style="western"><surname>Della Schiava</surname><given-names>N.</given-names></name><name name-style="western"><surname>Millon</surname><given-names>A.</given-names></name></person-group><article-title>EndoSuture aneurysm repair versus fenestrated aneurysm repair in patients with short neck abdominal aortic aneurysm</article-title><source>J. Vasc. Surg.</source><year>2023</year><volume>77</volume><fpage>28</fpage><lpage>36.e3</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2022.08.035</pub-id><pub-id pub-id-type="pmid">36070845</pub-id></element-citation></ref><ref id="B40-jcm-13-05601"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paajanen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Karjalainen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jaroma</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tarkiainen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Manninen</surname><given-names>H.</given-names></name><name name-style="western"><surname>M&#228;kinen</surname><given-names>K.</given-names></name><name name-style="western"><surname>K&#228;rkk&#228;inen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Saari</surname><given-names>P.</given-names></name></person-group><article-title>Friendly Neck Anatomy Does Not Prevent Neck-Related Adverse Events After EVAR</article-title><source>Ann. Vasc. Surg.</source><year>2024</year><volume>104</volume><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2023.06.031</pub-id><pub-id pub-id-type="pmid">37454900</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jcm-13-05601-f001" orientation="portrait"><label>Figure 1</label><caption><p>Survival during the follow-up period in elective cases managed with the Endurant device. SE: standard error.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-05601-g001.jpg"/></fig><fig position="float" id="jcm-13-05601-f002" orientation="portrait"><label>Figure 2</label><caption><p>The estimated freedom from endoleak type Ia during follow-up in elective cases managed with the Endurant device. SE: standard error.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-05601-g002.jpg"/></fig><fig position="float" id="jcm-13-05601-f003" orientation="portrait"><label>Figure 3</label><caption><p>The estimated freedom from endoleak Ib rate during follow-up period in elective cases managed with the Endurant device. SE: standard error.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-05601-g003.jpg"/></fig><fig position="float" id="jcm-13-05601-f004" orientation="portrait"><label>Figure 4</label><caption><p>The estimated freedom from endoleak type III rate during follow-up in elective cases managed with the Endurant device. SE: standard error.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-05601-g004.jpg"/></fig><fig position="float" id="jcm-13-05601-f005" orientation="portrait"><label>Figure 5</label><caption><p>The estimated freedom from any high-flow endoleak (type Ia, Ib and III) rate during follow-up in patients managed electively with the Endurant device. SE: standard error.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-05601-g005.jpg"/></fig><fig position="float" id="jcm-13-05601-f006" orientation="portrait"><label>Figure 6</label><caption><p>The estimated freedom from any reintervention rate during follow-up in patients managed electively with the Endurant device. SE: standard error.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-05601-g006.jpg"/></fig><table-wrap position="float" id="jcm-13-05601-t001" orientation="portrait"><object-id pub-id-type="pii">jcm-13-05601-t001_Table 1</object-id><label>Table 1</label><caption><p>Patients&#8217; comorbidities (CAD: coronary artery disease; CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; COPD: chronic obstructive pulmonary disease; CRD: chronic renal disease; eGFR: estimated glomerular filtration rate).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Comorbidity</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Patients</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Age (years)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.7 &#177; 7</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Males</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">347 (96%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm diameter (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62 &#177; 14</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">276 (77%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dyslipidemia</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">231 (64%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">221 (61%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAD</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">148 (41%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CABG</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56 (16%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCI</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 (14%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94 (26%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CRD </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26 (7%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal dialysis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (3%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 &#177; 0.4</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eGFR (mL/min)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.1 &#177; 6.3</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre-operative medical treatment </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acetylsalicylic acid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">187 (52%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clopidogrel</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44 (12%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Double aantiplatelet</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 (6%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anticoagulant</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43 (12%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Statin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">202 (56%)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="jcm-13-05601-t002" orientation="portrait"><object-id pub-id-type="pii">jcm-13-05601-t002_Table 2</object-id><label>Table 2</label><caption><p>Pre-operative anatomical characteristics of the aorta and the iliac arteries; AAA: abdominal aortic aneurysm; RCIA: right common iliac artery; REIA: right external iliac artery; LCIA: left common iliac artery; LEIA: left external iliac artery.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Anatomic Aortic Characteristic</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Value</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean AAA Diameter (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62 &#177; 14</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neck Characteristics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean Diameter (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.7 &#177; 5</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean Length (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#177; 11</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean Infra-renal Angulation (&#176;)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 &#177; 20</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean Supra-renal Angulation (&#176;)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.5 &#177; 19</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Neck Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">177</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mild Neck Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">107</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate Neck Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe Neck Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Neck Thrombus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mild Neck Thrombus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate Neck Thrombus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe Neck Thrombus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iliac Artery Characteristics </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean RCIA Diameter (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 &#177; 8</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean RCIA Angulation (&#176;)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 &#177; 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No RCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mild RCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">149</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate RCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe RCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean REIA Diameter (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 &#177; 1.6</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean LCIA Diameter (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 &#177; 5</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean LCIA Angulation (&#176;)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45 &#177; 25</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No LCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mild LCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate LCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe LCIA Calcification</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean LEIA Diameter (mm)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.1 &#177; 1.5</td></tr></tbody></table></table-wrap><table-wrap position="float" id="jcm-13-05601-t003" orientation="portrait"><object-id pub-id-type="pii">jcm-13-05601-t003_Table 3</object-id><label>Table 3</label><caption><p>Time and type of reinterventions that patients received during the follow-up period. N: number; fem-fem: femoro-femoral; ax-fem: axillo-femoral; AUI: aorto-uni-iliac; PG-EVAR: parallel graft endovascular aortic aneurysm repair; BEVAR: branched endovascular aortic aneurysm repair.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Time in Months</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N of Patients </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Open Conversion</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Aortic Cuff</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Iliac Extension</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Iliac Relining</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Femoral-Femoral Bypass</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Axillo-Femoral Bypass</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AUI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PG-EVAR</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BEVAR</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type II Endoleak Embolization</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>